Skip to main content

Editas Medicine, Inc 10-Q for FY2025 Q2

Editas Medicine, Inc. (EDIT)

10-Q 2025-08-12 For: 2025-06-30
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on August 12, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3.58M
up 597.5% from $513K a year earlier
Net loss
$53.24M
compared with a net loss of $67.61M a year earlier
Diluted EPS
-$0.63
compared with -$0.82 a year earlier